Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2020 1
2021 1
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Hepatotoxicity of molecular targeted therapy.
Karczmarek-Borowska B, Sałek-Zań A. Karczmarek-Borowska B, et al. Among authors: salek zan a. Contemp Oncol (Pozn). 2015;19(2):87-92. doi: 10.5114/wo.2014.43495. Epub 2014 Aug 29. Contemp Oncol (Pozn). 2015. PMID: 26034384 Free PMC article. Review.
First-line treatment of advanced/metastatic melanoma with anti-PD-1 antibodies: multicenter experience in Poland.
Cybulska-Stopa B, Pacholczak-Madej R, Kamińska-Winciorek G, Ziętek M, Czarnecka AM, Piejko K, Galus Ł, Ziółkowska B, Kieszko S, Kempa-Kamińska N, Calik J, Rolski J, Sałek-Zań A, Gajewska-Wicher K, Drosik-Kwaśniewska A, Rogala P, Kubiatowski T, Suwiński R, Mackiewicz J, Rutkowski P. Cybulska-Stopa B, et al. Among authors: salek zan a. Immunotherapy. 2021 Mar;13(4):297-307. doi: 10.2217/imt-2020-0217. Epub 2020 Dec 23. Immunotherapy. 2021. PMID: 33353420
Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients-Real-World Evidence.
Rogala P, Czarnecka AM, Cybulska-Stopa B, Ostaszewski K, Piejko K, Ziętek M, Dziura R, Rutkowska E, Galus Ł, Kempa-Kamińska N, Calik J, Sałek-Zań A, Zemełka T, Bal W, Kamycka A, Świtaj T, Kamińska-Winciorek G, Suwiński R, Mackiewicz J, Rutkowski P. Rogala P, et al. Among authors: salek zan a. J Clin Med. 2022 Apr 17;11(8):2239. doi: 10.3390/jcm11082239. J Clin Med. 2022. PMID: 35456332 Free PMC article.
Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland.
Sigorski D, Wilk M, Gawlik-Urban A, Sałek-Zań A, Kiszka J, Malik M, Czerko K, Kuć K, Szczylik C, Kubiatowski T, Cybulska-Stopa B, Filipczyk-Cisarż E, Bodnar L, Skoneczna I. Sigorski D, et al. Among authors: salek zan a. Front Oncol. 2023 Apr 3;13:1108937. doi: 10.3389/fonc.2023.1108937. eCollection 2023. Front Oncol. 2023. PMID: 37077831 Free PMC article.
Cancer care for Ukrainian refugees during the first 6 weeks of 2022 Russian invasion - An experience of a cancer reference centre in Poland.
Püsküllüoğlu M, Grela-Wojewoda A, Szczubiałka G, Zemełka T, Lompart J, Sałek-Zań A, Kopciński T, Pasieka E, Adamczyk A, Mucha-Małecka A, Kłęk S, Ryś J, Ziobro M. Püsküllüoğlu M, et al. Among authors: salek zan a. Eur J Cancer. 2023 Jan;178:234-242. doi: 10.1016/j.ejca.2022.10.005. Epub 2022 Oct 20. Eur J Cancer. 2023. PMID: 36371305 Free article.